
Hologic to Aid H5N1 Bird Flu Test Development in CDC Agreement
Hologic, Inc. (Nasdaq: HOLX) announced today that it has signed an agreement with the Centers for Disease Control and Prevention (CDC) to develop analyte specific reagents (ASRs) — key components…












